The challenge of cardiomyopathy

Department of Medicine, Charles A. Dana Research Institute, Beth Israel Hospital, Boston, Massachusetts 02215.

The combined clinical and pathophysiologic characteristics and diagnostic features as well as current concepts of pathogenesis, therapy and prevention of the principal forms of cardiomyopathy are reviewed. These include hypertrophic cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy and specific cardiac muscle disease. Emphasis is placed on recent developments and unresolved questions requiring application of newer techniques of molecular biology and genetics and adult myocyte culturing.

This article has been cited by other articles:

				H. Kondoh, Y. Sawa, S. Miyagawa, S. Sakakida-Kitagawa, I. A. Memon, N. Kawaguchi, N. Matsuura, T. Shimizu, T. Okano, and H. Matsuda Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters Cardiovasc Res, February 1, 2006; 69(2): 466 - 475. [Abstract] [Full Text] [PDF]

				H. Kondoh, Y. Sawa, N. Fukushima, G. Matsumiya, S. Miyagawa, S. Kitagawa-Sakakida, I. A. Memon, N. Kawaguchi, N. Matsuura, and H. Matsuda Reorganization of cytoskeletal proteins and prolonged life expectancy caused by hepatocyte growth factor in a hamster model of late-phase dilated cardiomyopathy J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 295 - 302. [Abstract] [Full Text] [PDF]

				J. Bogaert, M. Goldstein, F. Tannouri, J. Golzarian, and S. Dymarkowski Late Myocardial Enhancement in Hypertrophic Cardiomyopathy with Contrast-Enhanced MR Imaging Am. J. Roentgenol., April 1, 2003; 180(4): 981 - 985. [Abstract] [Full Text] [PDF]

				N.E. Bowles The molecular biology of dilated cardiomyopathy Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I2 - I7. [Abstract] [PDF]

				M. Noutsias, M. Pauschinger, H.-P. Schultheiss, and U. Kuhl Advances in the immunohistological diagnosis of inflammatory cardiomyopathy Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I54 - I62. [Abstract] [PDF]

				M. Sato, T. Toyozaki, K. Odaka, T. Uehara, Y. Arano, H. Hasegawa, K. Yoshida, K. Imanaka-Yoshida, T. Yoshida, M. Hiroe, et al. Detection of Experimental Autoimmune Myocarditis in Rats by 111In Monoclonal Antibody Specific for Tenascin-C Circulation, September 10, 2002; 106(11): 1397 - 1402. [Abstract] [Full Text] [PDF]

				J Hoffmann, W Grimm, V Menz, H-H Müller, and B Maisch Heart rate variability and baroreflex sensitivity in idiopathic dilated cardiomyopathy Heart, May 1, 2000; 83(5): 531 - 538. [Abstract] [Full Text]

				B. Lauer, M. Schannwell, U. Kuhl, B.-E. Strauer, and H.-P. Schultheiss Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis J. Am. Coll. Cardiol., January 1, 2000; 35(1): 11 - 18. [Abstract] [Full Text] [PDF]

				S. Winter, K. Jue, J. Prochazka, P. Francis, W. Hamilton, L. Linn, and E. Helton The Role of L-Carnitine in Pediatric Cardiomyopathy J Child Neurol, November 1, 1995; 10(2_suppl): 2S45 - 2S51. [Abstract] [PDF]

				A. Matsumori, Y. Matoba, and S. Sasayama Dilated Cardiomyopathy Associated With Hepatitis C Virus Infection Circulation, November 1, 1995; 92(9): 2519 - 2525. [Abstract] [Full Text]

				D. Neglia, O. Parodi, M. Gallopin, G. Sambuceti, A. Giorgetti, L. Pratali, P. Salvadori, C. Michelassi, M. Lunardi, G. Pelosi, et al. Myocardial Blood Flow Response to Pacing Tachycardia and to Dipyridamole Infusion in Patients With Dilated Cardiomyopathy Without Overt Heart Failure : A Quantitative Assessment by Positron Emission Tomography Circulation, August 15, 1995; 92(4): 796 - 804. [Abstract] [Full Text]